Actinium Pharmaceuticals, Inc.
ATNM- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001388320
No open-market purchases or sales by Actinium Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $5.18M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Actinium Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Actinium Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Shetty Ajit | Director | 62,357 | Sep 4, 2026 | 1 |
| Nicholson, C. David | Director | 63,300 | Sep 4, 2026 | 1 |
| Almenoff June Sherie | Director | 18,000 | Sep 4, 2026 | 1 |
| Seth Sandesh | Chief Executive Officer | 1,965,355 | Sep 4, 2026 | 1 |
| Steinhart Richard I | Director | 63,116 | Sep 4, 2026 | 1 |
| Chell Jeffrey W. | Director | 61,600 | Sep 4, 2026 | 1 |
| O'Loughlin Steve | Chief Financial Officer | – | Apr 2, 2025 | 0 |
| Berger Mark Stanley | Chief Medical Officer | – | Sep 3, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.